Sökning: "Disease modeling"
Visar resultat 11 - 15 av 194 avhandlingar innehållade orden Disease modeling.
11. Modeling Amyloid-β Pathology in Alzheimer’s Disease Using the Arctic Mutation
Sammanfattning : The Arctic mutation in the Amyloid-β (Aβ) domain of the Amyloid-β precursor protein (APP) causes Alzheimer’s disease (AD) and confers unique biochemical characteristics to Aβ peptides. The aims of this thesis were to evaluate a transgenic model with the Arctic mutation, and to use it to gain new insights into the mechanisms of early (pre-plaque) and late-stage Aβ pathogenesis in AD. LÄS MER
12. Imported infections’ importance : global change driving Dengue dynamics
Sammanfattning : Background Dengue is a significant problem of international health concern. According to the World Health Organization in 2012, globally, dengue is “the most important mosquito borne viral disease” with incidence 30 higher than it had been 50 years ago. LÄS MER
13. Integrative Modeling of Epigenetic Regulation in Human Disease
Sammanfattning : Glioblastoma is the most common and aggressive primary brain tumor. Standard of treatment prove ineffective, leading to tumor recurrence and an average survival rate of 14 months. This treatment resistance is attributed to both inter-tumor and intra-tumor heterogeneity observed across diverse tumor samples and within individual cells. LÄS MER
14. Prevention of type 2 diabetes : modeling the cost-effectiveness of diabetes prevention
Sammanfattning : Background: Diabetes is a common and costly disease that is expected to continue even to grow in prevalence and health expenditures over the coming decades. Type 2 diabetes is the most common diabetes type and is characterized by insulin resistance and relative insulin deficiency. LÄS MER
15. Molecular epidemiology approach : nested case-control studies in glioma and lymphoid malignancies
Sammanfattning : BACKGROUND: Nested case-control studies aim to link molecular markers with a certain outcome. Repeated prediagnostic samples may improve the evaluation of marker-disease associations. However, data regarding the benefit of repeated samples in such studies are sparse. LÄS MER